194 related articles for article (PubMed ID: 24919373)
41. Neural Invasion is a Significant Contributor to Peritoneal Recurrence in Signet Ring Cell Gastric Carcinoma.
Lee D; Son SY; Kim YB; Han SU; Hur H
Ann Surg Oncol; 2018 May; 25(5):1167-1175. PubMed ID: 29450754
[TBL] [Abstract][Full Text] [Related]
42. Treatment outcomes in patients with signet ring cell carcinoma of the colorectum.
Lee WS; Chun HK; Lee WY; Yun SH; Cho YB; Yun HR; Park SH; Song SY
Am J Surg; 2007 Sep; 194(3):294-8. PubMed ID: 17693269
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathologic features of gastric carcinoma patients who undergo a total gastrectomy.
Joo JK; Kim HG; Ryu SY; Lee JH; Kim DY
Int Surg; 2010; 95(2):147-52. PubMed ID: 20718322
[TBL] [Abstract][Full Text] [Related]
44. General and specific prognostic factors of early gastric carcinoma treated with curative surgery.
Isozaki H; Tanaka N; Okajima K
Hepatogastroenterology; 1999; 46(27):1800-8. PubMed ID: 10430349
[TBL] [Abstract][Full Text] [Related]
45. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
Shi C; Yang B; Chen Q; Yang J; Fan N
Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
[TBL] [Abstract][Full Text] [Related]
46. Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study.
Tung SY; Wu CS; Chen PC
Am J Gastroenterol; 1996 Oct; 91(10):2195-9. PubMed ID: 8855747
[TBL] [Abstract][Full Text] [Related]
47. Clinical Characteristics and Prognostic Analysis of Patients With Signet Ring Cell Gastric Carcinoma.
Yu JM; Zhan ZW; Zhen JX; Wang XJ; Chen Y; Lin J; Chen L; Chen LZ; Huang YF; Guo ZQ
Technol Cancer Res Treat; 2020; 19():1533033820983812. PubMed ID: 33371800
[TBL] [Abstract][Full Text] [Related]
48. Gastric cancer histology: clinicopathologic characteristics and prognostic value.
Park JM; Jang YJ; Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS
J Surg Oncol; 2008 Dec; 98(7):520-5. PubMed ID: 18802956
[TBL] [Abstract][Full Text] [Related]
49. Undifferentiated-type gastric adenocarcinoma: prognostic impact of three histological types.
Lee HH; Song KY; Park CH; Jeon HM
World J Surg Oncol; 2012 Nov; 10():254. PubMed ID: 23181547
[TBL] [Abstract][Full Text] [Related]
50. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
[TBL] [Abstract][Full Text] [Related]
51. Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma.
Lemoine N; Adenis A; Bouche O; Duhamel A; Heurgue A; Leteurtre E; Amela E; Salleron J; Hebbar M
Anticancer Res; 2016 Oct; 36(10):5543-5549. PubMed ID: 27798928
[TBL] [Abstract][Full Text] [Related]
52. Large tumor size is a poor prognostic factor of gastric cancer with signet ring cell: Results from the surveillance, epidemiology, and end results database.
Zhou L; Li W; Cai S; Yang C; Liu Y; Lin Z
Medicine (Baltimore); 2019 Oct; 98(40):e17367. PubMed ID: 31577736
[TBL] [Abstract][Full Text] [Related]
53. Impact of histopathology on the outcome of D1/D2 gastrectomies with R0 resection.
Uslu A; Bati H; Postaci H; Nart A; Eliyatkin N; Yetis H; Corumlu B; Aykas A; Zengel B
Digestion; 2012; 86(1):67-73. PubMed ID: 22777320
[TBL] [Abstract][Full Text] [Related]
54. Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma.
Fang WL; Wu CW; Lo SS; Chen JH; Hsieh MC; Shen KH; Li AF; Tai LC; Lui WY
Hepatogastroenterology; 2009; 56(93):1227-31. PubMed ID: 19760976
[TBL] [Abstract][Full Text] [Related]
55. Early signet ring cell gastric cancer.
Chiu CT; Kuo CJ; Yeh TS; Hsu JT; Liu KH; Yeh CN; Hwang TL; Jan YY; Lin CJ
Dig Dis Sci; 2011 Jun; 56(6):1749-56. PubMed ID: 21104129
[TBL] [Abstract][Full Text] [Related]
56. Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology.
Lee JH; Choi IJ; Kook MC; Nam BH; Kim YW; Ryu KW
Br J Surg; 2010 May; 97(5):732-6. PubMed ID: 20235088
[TBL] [Abstract][Full Text] [Related]
57. Signet Ring Cell Histology Confers Worse Overall Survival in Treated Esophageal Adenocarcinoma.
Tang A; Rappaport J; Raja S; Bribriesco AC; Sudarshan M; Siddiqui HU; Raymond D; Murthy SC; Ahmad U
Ann Thorac Surg; 2021 Jan; 111(1):214-222. PubMed ID: 32579884
[TBL] [Abstract][Full Text] [Related]
58. Signet ring gastric and esophageal adenocarcinomas: characteristics and prognostic implications.
Khan N; Donohoe CL; Phillips AW; Griffin SM; Reynolds JV
Dis Esophagus; 2020 Nov; 33(11):. PubMed ID: 32378712
[TBL] [Abstract][Full Text] [Related]
59. Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil.
Fanelli MF; de Paiva TF; Silva MJ; Benevides CF; Guimarães AP; Gimenes DL; Pinheiro ED; Rinck JA; Nicolau UR; Sanches SM; Mello CA; Dettino AL; Cruz MR; de Melo LM; Formiga MN; de Lima VC; Chinen LT
J Surg Oncol; 2009 Nov; 100(6):452-5. PubMed ID: 19697363
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma.
Liang C; Liang Y; Ou B; Yuan L; Yuan S
Saudi J Gastroenterol; 2023; 29(4):240-250. PubMed ID: 37470667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
